mebendazole has been researched along with Premature Birth in 1 studies
Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
Premature Birth: CHILDBIRTH before 37 weeks of PREGNANCY (259 days from the first day of the mother's last menstrual period, or 245 days after FERTILIZATION).
Excerpt | Relevance | Reference |
---|---|---|
"664) was found between the mebendazole group and the placebo group in terms of numbers of miscarriages, malformations, stillbirths, early neonatal deaths and premature babies (28 versus 31, respectively)." | 5.12 | Lack of risk of adverse birth outcomes after deworming in pregnant women. ( Casapia, M; Gotuzzo, E; Gyorkos, TW; Larocque, R, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gyorkos, TW | 1 |
Larocque, R | 1 |
Casapia, M | 1 |
Gotuzzo, E | 1 |
1 trial available for mebendazole and Premature Birth
Article | Year |
---|---|
Lack of risk of adverse birth outcomes after deworming in pregnant women.
Topics: Animals; Antinematodal Agents; Birth Weight; Double-Blind Method; Endemic Diseases; Female; Hookworm | 2006 |